Puma Biotechnology Stock Forecast - Simple Moving Average
| PBYI Stock | USD 6.86 0.03 0.44% |
The Simple Moving Average forecasted value of Puma Biotechnology on the next trading day is expected to be 6.86 with a mean absolute deviation of 0.15 and the sum of the absolute errors of 8.80. Puma Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Puma Biotechnology's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 23rd of January 2026 the rsi of Puma Biotechnology's share price is below 20 indicating that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Quarterly Earnings Growth (0.58) | EPS Estimate Next Quarter 0.36 | EPS Estimate Current Year 0.69 | EPS Estimate Next Year 0.55 | Wall Street Target Price 3.5 |
Using Puma Biotechnology hype-based prediction, you can estimate the value of Puma Biotechnology from the perspective of Puma Biotechnology response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Puma Biotechnology using Puma Biotechnology's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Puma using crowd psychology based on the activity and movement of Puma Biotechnology's stock price.
Puma Biotechnology Short Interest
A significant increase or decrease in Puma Biotechnology's short interest from the previous month could be a good indicator of investor sentiment towards Puma. Short interest can provide insight into the potential direction of Puma Biotechnology stock and how bullish or bearish investors feel about the market overall.
200 Day MA 4.4073 | Short Percent 0.0799 | Short Ratio 8.99 | Shares Short Prior Month 3.4 M | 50 Day MA 5.61 |
Puma Biotechnology Hype to Price Pattern
Investor biases related to Puma Biotechnology's public news can be used to forecast risks associated with an investment in Puma. The trend in average sentiment can be used to explain how an investor holding Puma can time the market purely based on public headlines and social activities around Puma Biotechnology. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Puma Biotechnology Implied Volatility | 1.32 |
Puma Biotechnology's implied volatility exposes the market's sentiment of Puma Biotechnology stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Puma Biotechnology's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Puma Biotechnology stock will not fluctuate a lot when Puma Biotechnology's options are near their expiration.
The Simple Moving Average forecasted value of Puma Biotechnology on the next trading day is expected to be 6.86 with a mean absolute deviation of 0.15 and the sum of the absolute errors of 8.80. Puma Biotechnology after-hype prediction price | USD 6.83 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Puma Biotechnology to cross-verify your projections. Open Interest Against 2026-03-20 Puma Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Puma Biotechnology's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Puma Biotechnology's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Puma Biotechnology stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Puma Biotechnology's open interest, investors have to compare it to Puma Biotechnology's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Puma Biotechnology is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Puma. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Puma Biotechnology Additional Predictive Modules
Most predictive techniques to examine Puma price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Puma using various technical indicators. When you analyze Puma charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Puma Biotechnology Simple Moving Average Price Forecast For the 24th of January
Given 90 days horizon, the Simple Moving Average forecasted value of Puma Biotechnology on the next trading day is expected to be 6.86 with a mean absolute deviation of 0.15, mean absolute percentage error of 0.05, and the sum of the absolute errors of 8.80.Please note that although there have been many attempts to predict Puma Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Puma Biotechnology's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Puma Biotechnology Stock Forecast Pattern
| Backtest Puma Biotechnology | Puma Biotechnology Price Prediction | Buy or Sell Advice |
Puma Biotechnology Forecasted Value
In the context of forecasting Puma Biotechnology's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Puma Biotechnology's downside and upside margins for the forecasting period are 2.11 and 11.61, respectively. We have considered Puma Biotechnology's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Puma Biotechnology stock data series using in forecasting. Note that when a statistical model is used to represent Puma Biotechnology stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.4264 |
| Bias | Arithmetic mean of the errors | -0.0408 |
| MAD | Mean absolute deviation | 0.1491 |
| MAPE | Mean absolute percentage error | 0.0268 |
| SAE | Sum of the absolute errors | 8.795 |
Predictive Modules for Puma Biotechnology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Puma Biotechnology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Puma Biotechnology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Puma Biotechnology After-Hype Price Prediction Density Analysis
As far as predicting the price of Puma Biotechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Puma Biotechnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Puma Biotechnology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Puma Biotechnology Estimiated After-Hype Price Volatility
In the context of predicting Puma Biotechnology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Puma Biotechnology's historical news coverage. Puma Biotechnology's after-hype downside and upside margins for the prediction period are 2.08 and 11.58, respectively. We have considered Puma Biotechnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Puma Biotechnology is relatively risky at this time. Analysis and calculation of next after-hype price of Puma Biotechnology is based on 3 months time horizon.
Puma Biotechnology Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Puma Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Puma Biotechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Puma Biotechnology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.55 | 4.75 | 0.03 | 0.00 | 7 Events / Month | 6 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
6.86 | 6.83 | 0.44 |
|
Puma Biotechnology Hype Timeline
Puma Biotechnology is at this time traded for 6.86. The entity has historical hype elasticity of -0.03, and average elasticity to hype of competition of 0.0. Puma is anticipated to decline in value after the next headline, with the price expected to drop to 6.83. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.44%, whereas the daily expected return is at this time at 0.55%. The volatility of related hype on Puma Biotechnology is about 213750.0%, with the expected price after the next announcement by competition of 6.86. About 15.0% of the company outstanding shares are owned by corporate insiders. The book value of Puma Biotechnology was at this time reported as 2.29. The company has Price/Earnings To Growth (PEG) ratio of 0.03. Puma Biotechnology had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 7 days. Check out Historical Fundamental Analysis of Puma Biotechnology to cross-verify your projections.Puma Biotechnology Related Hype Analysis
Having access to credible news sources related to Puma Biotechnology's direct competition is more important than ever and may enhance your ability to predict Puma Biotechnology's future price movements. Getting to know how Puma Biotechnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Puma Biotechnology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ELDN | Eledon Pharmaceuticals | (0.04) | 41 per month | 9.73 | (0.01) | 10.06 | (7.95) | 70.46 | |
| ABEO | Abeona Therapeutics | 0.04 | 8 per month | 3.55 | (0.01) | 6.16 | (5.49) | 26.76 | |
| VYGR | Voyager Therapeutics | (0.08) | 12 per month | 0.00 | (0.17) | 4.14 | (6.35) | 19.71 | |
| AVIR | Atea Pharmaceuticals | (0.04) | 9 per month | 3.07 | 0.07 | 4.64 | (3.27) | 17.80 | |
| ARCT | Arcturus Therapeutics Holdings | 0.37 | 8 per month | 0.00 | (0.17) | 6.53 | (7.02) | 57.84 | |
| ALLO | Allogene Therapeutics | (0.04) | 11 per month | 3.27 | 0.11 | 9.76 | (5.93) | 21.23 | |
| HUMA | Humacyte | (0.07) | 11 per month | 0.00 | (0.19) | 6.19 | (8.13) | 19.22 | |
| TRDA | Entrada Therapeutics | (0.24) | 12 per month | 2.04 | 0.28 | 6.98 | (4.00) | 15.00 | |
| SGMT | Sagimet Biosciences Series | 0.12 | 10 per month | 0.00 | (0.04) | 6.39 | (7.51) | 36.94 |
Other Forecasting Options for Puma Biotechnology
For every potential investor in Puma, whether a beginner or expert, Puma Biotechnology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Puma Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Puma. Basic forecasting techniques help filter out the noise by identifying Puma Biotechnology's price trends.Puma Biotechnology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Puma Biotechnology stock to make a market-neutral strategy. Peer analysis of Puma Biotechnology could also be used in its relative valuation, which is a method of valuing Puma Biotechnology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Puma Biotechnology Market Strength Events
Market strength indicators help investors to evaluate how Puma Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Puma Biotechnology shares will generate the highest return on investment. By undertsting and applying Puma Biotechnology stock market strength indicators, traders can identify Puma Biotechnology entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 6.86 | |||
| Day Typical Price | 6.86 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.03) |
Puma Biotechnology Risk Indicators
The analysis of Puma Biotechnology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Puma Biotechnology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting puma stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.72 | |||
| Semi Deviation | 4.16 | |||
| Standard Deviation | 4.67 | |||
| Variance | 21.78 | |||
| Downside Variance | 20.09 | |||
| Semi Variance | 17.26 | |||
| Expected Short fall | (3.15) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Puma Biotechnology
The number of cover stories for Puma Biotechnology depends on current market conditions and Puma Biotechnology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Puma Biotechnology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Puma Biotechnology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Puma Biotechnology Short Properties
Puma Biotechnology's future price predictability will typically decrease when Puma Biotechnology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Puma Biotechnology often depends not only on the future outlook of the potential Puma Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Puma Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 49.1 M | |
| Cash And Short Term Investments | 101 M |
Check out Historical Fundamental Analysis of Puma Biotechnology to cross-verify your projections. For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Puma Biotechnology. If investors know Puma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Puma Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.58) | Earnings Share 0.74 | Revenue Per Share | Quarterly Revenue Growth (0.32) | Return On Assets |
The market value of Puma Biotechnology is measured differently than its book value, which is the value of Puma that is recorded on the company's balance sheet. Investors also form their own opinion of Puma Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Puma Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Puma Biotechnology's market value can be influenced by many factors that don't directly affect Puma Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Puma Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Puma Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Puma Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.